Sansulin Log-G (insulin glargine biosimilar)
/ Sanbe
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 19, 2020
The Efficacy, Safety, and Immunogenicity Study Comparing an Insulin Glargine Biosimilar Sansulin Log-G to Lantus
(clinicaltrials.gov)
- P2; N=120; Not yet recruiting; Sponsor: Indonesia University
Clinical • New P2 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 1
Of
1
Go to page
1